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The aim of this study was to examine the role of oxidative DNA damage in chronic liver inﬂammation in
the evolution of hepatocellular carcinoma. The accumulated data demonstrated that oxidative DNA da-
mage and chronic liver inﬂammation are involved in the transformation of normal hepatocytes and their
evolution towards hepatocellular carcinoma. However, the levels of 8-oxy-2′-deoxy-guanosine (8-ox-
odG), a biomarker of oxidative DNA damage, were overestimated and underestimated in previous reports
due to various technical limitations. The current techniques are not suitable to analyze the 8-oxodG
levels in the non-malignant liver tissues and tumors of hepatocellular carcinoma patients unless they are
modiﬁed. Therefore, in this study, the protocols for extraction and hydrolysis of DNA were optimized
using 54 samples from hepatocellular carcinoma patients with various risk factors, and the 8-oxodG and
2′-deoxyguanosine (dG) levels were measured. The patients enrolled in the study include 23 from The
Princess Alexandra Hospital and The Royal Brisbane and Women's Hospitals, Brisbane, Australia, and 31
from South Africa. This study revealed that the 8-oxodG/dG ratios tended to be higher in most non-
malignant liver tissues compared to hepatocellular carcinoma tissue (p¼0.2887). It also appeared that
the ratio was higher in non-malignant liver tissue from Southern African patients (p¼0.0479), but there
was no difference in the 8-oxodG/dG ratios between non-malignant liver tissues and tumors of Aus-
tralian hepatocellular carcinoma patients (p¼0.7722). Additionally, this study also revealed a trend for a
higher 8-oxodG/dG ratio in non-malignant liver tissues compared to tumoural tissues of patients with
HBV. Signiﬁcant differences were not observed in the 8-oxodG/dG ratios between non-cirrhotic and
cirrhotic non-malignant liver tissues.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The mechanisms of hepatocarcinogenesis are incompletely
understood [1–3]. Mounting evidence indicates that oxidative DNA
damage caused by reactive oxygen species (ROS) and reactive ni-
trogen species (RNS) accumulation in chronic liver inﬂammation
may play a role in hepatocarcinogenesis [4,5]. A number of in-
vestigators have suggested that hepatocellular carcinoma (HCC)
develops from the malignant transformation of hepatocytes, as
these cells acquire multiple ROS- and RNS-induced mutations in
key genes that control cell proliferation and death [6,7]. This as-
sumption has been supported by several observations. The pre-
valence of chromosomal gene alterations increases with the pro-
gression from chronic hepatitis to ﬁbrosis, cirrhosis, low grade
dysplasia, high grade dysplasia, early HCC, moderatelyB.V. This is an open access article
. Li).differentiated HCC and ﬁnally advanced HCC [8,9]. The epide-
miological data demonstrate that there is a strong relationship
between chronic liver inﬂammation and hepatocarcinogenesis
[10–12]. Approximately 80% of HCC cases are associated with
chronic liver inﬂammation and liver cirrhosis [13,14]. Chronic liver
inﬂammation may produce ROS [15,16] and RNS [17,18]. ROS and
RNS may cause DNA oxidation, nitrosylation, nitration, and halo-
genation, leading to mutations in key genes, including oncogenes
and tumoural suppressor genes [7,19,20]. These mutations likely
confer growth advantages on these cells, leading to the transfor-
mation of normal hepatocytes and their evolution towards HCC.
As mentioned in previous articles, 8-oxodG is one of the main
oxidation products of guanosine (dG) and is induced by ROS and
RNS [19,21,22]. The presence of 8-oxodG in DNA leads to mis-
reading and misinsertion of nucleotides during DNA synthesis,
leading to G-T and G-C conversions [23–25]. 8-oxodG can be
produced from continuous oxidative stresses associated with
chronic inﬂammation [21]. A previous study revealed that the
8-oxodG levels are elevated in some human pre-neoplastic lesionsunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tensively been used as an indicator of oxidative DNA damage [27]
and various diseases [28–30].
The picture is less clear for hepatocarcinogenesis. Furthermore,
it has not been completely conﬁrmed whether the genetic al-
terations induced by oxidative DNA damage are involved in the
malignant transformation of normal hepatocytes [31]. Currently,
one issue with the data is the concern about whether the arte-
factual production of 8-oxodG during DNA processing (DNA ex-
traction, hydrolysis and analysis) leads to an over- or under-
estimation of the role of 8-oxodG in malignant transformation
[32–34]. In the past, the accurate measurement of 8-oxodG in
samples of human liver tissue has been hampered by limitations in
the amount of tissue available for study, the incomplete release of
nucleosides, the artefactual formation of 8-oxodG during tissue
processing, and the limits of detection of the assays employed to
measure the 8-oxodG levels [27]. The European Standards Com-
mittee on Oxidative DNA Damage (ESCODD) and other in-
vestigators have attempted to develop reliable protocols for sam-
ple preparation and analysis, with minimal dG oxidation as a
consequence of sample preparation [27,35–39]. However, both
overestimation and underestimation of 8-oxodG concentrations
have been reported by ESCODD using various methods [37]. The
conclusion reached from reviewing the previous studies, including
those from ESCODD, is that the current techniques are not suitable
to analyze the 8-oxodG levels in non-malignant liver tissues and
tumors of HCC patients unless they are modiﬁed.
Therefore, in this study, the protocols for extracting and hy-
drolyzing patients' DNAs were optimized, and the 8-oxodG levels
were measured. This study evaluated the dose-dependent re-
lationships between the amount of 8-oxodG (determined from the
ratio of 8-oxodG/dG) and clinical variables in 54 patients with
HCC, with particular attention paid to optimizing the experimental
conditions to minimize the formation of 8-oxodG during the
process. The aim of this study was to examine the role of oxidative
DNA damage in the evolution of HCC by particularly focusing on
oxidative DNA damage in chronic liver inﬂammation.2. Materials
2.1. Samples
Frozen liver tissues from 54 HCC patients were studied in this
experiment. These liver tissues were collected by medical doctors
in hospitals in Australia and South Africa. Twenty-three patients
from The Princess Alexandra Hospital and The Royal Brisbane
Hospitals, Brisbane, Australia and 31 patients from South Africa
were enrolled in this study. The Australian cases were drawn from
a tissue bank, while the clinical material from South Africa was
obtained from Professor Michael Kew. The details of each case are
presented in Table 1. Both non-malignant liver tissues and HCC
tissues were available for some cases, while only non-malignant
liver tissues or HCC tissues were available from other cases. InTable 1
Characteristics of the patients with hepatocellular carcinoma.
Cases Available tissue Cirrhosis
Total Non-malignant liver tissues Tumor Non-cirrhosis
Total 54 47 45 13
Australia 23 19 16 8
Southern Africa 31 28 29 5
a UK – Unknown – no clinical data available.
* HBV – Hepatitis B; HC – Haemochromatosis; HCV – Hepatitis C; Nil – No identiﬁeaddition, the clinical data were not complete for all cases; there-
fore, the data on the presence or absence of cirrhosis or on the risk
factors for chronic liver disease were not available for some cases.
These studies were approved by the Human Research Ethics
Committee of the Royal Brisbane Hospital and the University of
Queensland.3. Methods
3.1. Reagents
Zinc chloride, magnesium chloride, calcium chloride, sodium
chloride, sodium acetate, guanidine thiocyanate, 2,2,6,6-tetra-
methylpiperidine-Noxyl (TEMPO), chloroform, 2-propanol, iso-
amyl alcohol, nuclease P1, proteinase K, RNase A, alkaline phos-
phatase, catalase and Tween 20 were purchased from Sigma (St.
Louis, MO, USA). The Phase Lock Gel (PLG) tubes were purchased
from Eppendorf-Netheler-Hinz (Hamburg, Germany). Tris base
was purchased from Amresco (Solon, OH, USA).
3.2. Equipment
High Performance Liquid Chromatography – tandem mass
spectrometry was performed with a PE/Sciex API 300 mass spec-
trometer equipped with a turbo-ion spray interface coupled to a
Perkin Elmer series 200 HPLC system (Waltham, MA, USA) from
Queensland Health Scientiﬁc Services (39 Kessels Rd, Coopers
Plains Qld 4108, Au).
3.3. Preparation of the homogenization buffer and enzyme buffer
Homogenization buffer was prepared with 20 mM Tris, 5 mM
magnesium chloride, 50 U/ml catalase and 1 mM TEMPO and then
adjusted to pH 7.5. Tween 20 was dissolved in homogenization
buffer to a ﬁnal concentration of 0.5% Tween 20 (v/v). Guanidine
thiocyanate (GTC) was dissolved in Milli-Q water to produce a 4 M
GTC DNA extraction solution containing 4 M GTC, 50 U/ml catalase
and 1 mM TEMPO. One volume of isoamyl alcohol was mixed with
24 volumes of chloroform to produce the Sevag solution, as pre-
viously described. Antioxidants (catalase, TEMPO) were added to
all solutions, except 2-propanol and 70% v/v ethanol. Milli-Q water
was used throughout. All solutions, except the Sevag solution,
were stored in the dark at 4 °C in plastic bottles to avoid metal
contamination from glass.
The RNase A buffer consisted of 100 mg/ml RNase A, 2 mM
calcium chloride, and 20 mM Tris, pH 7.5. Proteinase K was added
to 2 mM calcium chloride and 20 mM Tris buffer (pH 7.5) to pre-
pare a 20 mg/ml proteinase K solution, which was stored at
20 °C. The hydrolysis buffer contained 25 mM sodium acetate
and 0.1 mM zinc chloride. The pH value of the hydrolysis buffer
was adjusted to 5.3, and it was then stored in a cold room. Nu-
clease P1 was dissolved in hydrolysis buffer containing 50 mM
sodium acetate and 0.2 mM zinc chloride to produce a 2.5 mg/mlRisk factors for chronic liver disease*
Cirrhosis UKa HBV HC HCV Alcohol Allagile's syndrome Nil
18 23 33 9 4 4 1 3
13 2 3 9 3 4 1 3
5 21 30 – 1 – – –
d cause of chronic liver disease.
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at 20 °C. The alkaline phosphatase solution and catalase were
stored at 4 °C.3.4. Comparison of the proteinase K digestion and 4 M GTC methods
of DNA extraction
Previous studies have shown that proteinase K digestion at
37 °C generates more artefactual 8-oxodG than the cold 4 M GTC
method at 0 °C. In this study, DNA from human liver tissues was
isolated with these two methods to compare their effects on the
efﬁciency of DNA extraction and the generation of 8-oxodG DNA so
that the method that generated the least amount of artefactual
8-oxodG could be used for the subsequent isolation of DNA from
human liver tissues.
Four frozen samples of human HCC tissues and four samples of
normal human liver tissues were studied. The samples were dis-
tributed according to the method of extraction (Groups One and
Two). Each group consisted of two HCC samples and two normal
liver tissue samples. In a cold room, 50 mg of each tissue was
homogenized with a high speed homogenizer. The homogenate
was centrifuged at 1000g for 5 min. The supernatant was dis-
carded, and the nuclear pellets were washed twice with Tween 20
buffer, followed by centrifugation at 1000g for 5 min after each
wash. The nuclear pellets of Group One were used to isolate DNA
by proteinase K digestion, whereas the Group Two samples were
stored in the cold room to isolate DNA using the cold 4 M GTC
method.
The nuclear pellets of each sample in Group one were dissolved
in 540 ml of RNase A buffer and incubated in a 37 °C water bath for
30 min. Subsequently, 14 ml of proteinase K was added and in-
cubated at 37 °C for 45 min. The solution was transferred to a
prespun 2.0-ml PLG tube (heavy) and 560 ml of Sevag solution was
added. The tubes were centrifuged at 13,000g for 5 min. This led to
the formation of a mixed organic/aqueous solution in which the
proteins and lipids precipitated in the organic phases in the PLG
tubes and the DNA remained in upper aqueous phases. This su-
pernatant was transferred to a 2-ml PLG tube (light), and then, an
additional 560 ml of Sevag solution was added. These tubes were
mixed and centrifuged at 13,000g for 5 min. The upper aqueous
phase containing the DNA was transferred to a new 2-ml tube.
Seventy-ﬁve microliters of a 5 M sodium chloride solution and
635 ml of isopropanol were added to each tube. After mixing, DNA
was precipitated at 20 °C for 15 min and then centrifuged at
20,800g for 10 min. The supernatant was discarded, and DNA was
stored at 80 °C prior to hydrolysis.
The crude nuclei of each sample in Group Two were completely
dissolved in 850 ml of cold (0 °C) 4 M GTC solution in a cold room.
The solution was transferred to a 2-ml PLG tube (heavy). Eight-
hundred-ﬁfty microliters of Sevag solution were added to this
tube. The tube was centrifuged at 13,000g, and then, the upper
phase containing the DNA was transferred to 2-ml PLG tube (light)
before an additional 850 ml of Sevag solution was added. These
tubes were mixed and centrifuged at 13,000g for 5 min. Then, the
upper aqueous phase containing the DNAwas transferred to a new
2-ml tube and 850 ml of 2-isopropanol was added and incubated at
20 °C for 15 min to precipitate the DNA. DNA was pelleted by
centrifugation at 20,800g for 10 min, and the samples were stored
at 80 °C prior to hydrolysis.
The DNA samples from Groups One and Two were hydrolyzed
with 2 mg of nuclease P1 and 1 unit of alkaline phosphatase for 1 h
at 50 °C for 1 h. The concentrations of 8-oxodG and dG were
measured by HPLC-MS/MS.3.5. Enzymatic hydrolysis of commercial calf thymus DNA
Accumulating data reveal that the ratios of 8-oxodG/dG vary in
repeated measurements of the same samples from different in-
dividuals and in different laboratories [37], as well as those using
different methods for sample preparation [27,40] and different
methods for detecting 8-oxodG [27]. These variations were up to
several orders of magnitude. For example, the quantity of 8-oxodG
from lymphocyte DNA was 4.24 per 106 dG measured using HPLC,
whereas it was 0.34 8-oxodG per 106 dG measured using the co-
met assay [27]. Concentrations of 8-oxodG ranged from 2.23 to 441
8-oxodG per106 dG in DNA from pig liver using HPLC techniques
[40]. The inconsistency in the quantitation of the 8-oxodG/dG ra-
tios implies that the actual amount of 8-oxodG in DNA cannot be
determined as a result of the unsuitable hydrolysis conditions
during processing. The release of 8-oxodG from DNA during en-
zymatic hydrolysis is inﬂuenced by a few factors, including the
DNA concentration, choice of enzymes, enzymatic activities, in-
cubation time and incubation temperatures. Excessive DNA, un-
suitable enzymes, short incubation times and low temperatures
may cause incomplete hydrolysis of DNA, while high temperature
generates artefactual 8-oxodG. These drawbacks can result in an
overestimation or underestimation of the 8-oxodG concentrations
[32,41]. Currently, most protocols of DNA hydrolysis are performed
with approximately 100 mg of DNA, 1 to 20 mg of nuclease P1 (P1)
and 0.5–20 U/ml of alkaline phosphatase for a few minutes to
hours at 37 °C or overnight in a cold room [27,41,42]. However,
100 mg of DNA are not completely hydrolyzed by 1 U/ml of nu-
clease P1 during a 1.5 h incubation hours at 37 °C, followed by a
1 h incubation at 37 °C with 1 U/ml of alkaline phosphatase, even
if the doses of nuclease P1 or alkaline phosphatase are increased
[41]. Nuclease P1 and alkaline phosphatase can more rapidly and
efﬁciently hydrolyze DNA at high temperatures, such as 65 °C,
compared to 37 °C, but incubation periods in excess of 15 min at
65 °C increase the levels of artefactual 8-oxodG [43]. The dena-
turation of DNA into single stands by incubating it at high tem-
peratures is beneﬁcial for complete hydrolysis [41], but the 100 °C
temperature used to denature DNA may increase the levels of ar-
tefactual 8-oxodG. Another study shows that 100 mg of DNA plus
was completely hydrolyzed by 1 mg P1 and 1 U/ml alkaline phos-
phatase in 1 h at 50 °C and produced less artefactual 8-oxodG [32].
Therefore, in this study, ﬁve different hydrolysis conditions
were used to compare the generation of 8-oxodG in calf thymus
DNA. Based on these data, suitable hydrolysis conditions were
optimized for the subsequent hydrolysis of the DNA from human
liver tissues.
One-hundred micrograms of calf thymus DNA were dissolved
in 90 ml of a hydrolysis solution and then hydrolyzed with 1 mg,
5 mg, 10 mg or 20 mg of nuclease P1 plus 1 unit of alkaline phos-
phatase using the following conditions:
i. The DNA solution was digested with nuclease P1 and alkaline
phosphatase for 1 h at 50 °C.
ii. The DNA solution was ﬁrst boiled at 100 °C for 5 min in a mi-
crowave oven and then rapidly chilled on ice for 2 min. Next,
nuclease P1 and alkaline phosphatase were added to digest the
DNA and incubated for 1 h at 50 °C.
iii. The DNA solution was incubated with nuclease P1 for 1 h at
50 °C before it was incubated with alkaline phosphatase for 1 h
at 37 °C.
iv. The DNA solution was digested with nuclease P1 for 10 min at
65 °C and then treated with alkaline phosphatase for 1 h at
37 °C.
v. The DNA solution was digested with nuclease P1 for 30 min at
37 °C and then treated with alkaline phosphatase for 1 h at
37 °C.
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1.5-ml Phase Lock Gel (light) tube. One-hundred microliters of
Sevag solution was added to each tube, and the tubes were brieﬂy
mixed, and centrifuged at 13,000g for 5 min. The proteins and
Sevag solutions precipitated in the organic phase of the tube,
while 8-oxodG, dG and DNA remained in the upper phases. The
supernatant was transferred to a new 0.5-ml tube and stored at
80 °C before the 8-oxodG levels were measured by HPLC-MS/
MS.
3.6. DNA extraction from the human liver tissues using the 4 M GTC
method
The DNA from patients' liver tissues was isolated using the cold
4 M GTC method. All procedures were performed in a cold room,
unless stated otherwise. The dissection materials, reagents, 10-ml
ﬂat-bottom tubes and equipment used for DNA extraction were
pre-chilled. Approximately 50 mg of frozen liver tissue per sample
was cut on aluminum foil on dry ice, weighed, and immediately
placed into numbered 10-ml ﬂat-bottom tubes. One milliliter of
ice-cold homogenization buffer was added to each numbered 10-
ml tube on ice. The samples were completely homogenized with a
power homogenizer for three minutes. After each sample was
homogenized, the pestle was sequentially washed in pre-chilled
100% alcohol, Milli Q water and 100% alcohol, and then dried using
a Kimwipe tissue.
The homogenized solution for each sample was transferred
from the 10-ml ﬂat-bottom tube into a marked 2-ml centrifuge
tube. One milliliter of homogenization buffer was added to the 10-
ml ﬂat-bottom tube to wash the tube and then added to the 2-ml
tube. The solution was mixed with a vortex mixer for 1 min and
then placed on ice for 5 min before the crude nuclei were pelleted
by centrifugation at 1000g for 10 min. After discarding the su-
pernatant, which contains membranes, proteins, mitochondria
and most of the RNA, the nuclear fraction was re-suspended in one
ml of Tween 20 buffer and placed on ice for 5 min. The samples
were centrifuged at 1000g for 10 min, the supernatant was with-
drawn, and the nuclei were re-suspended in one ml of Tween 20
buffer and placed on ice for 5 min. The samples were centrifuged a
ﬁnal time at 1000g for 10 min, and the supernatants were
discarded
The pellets were dissolved in 850 ml of cold 4 M GTC by pi-
petting up and down to produce a clear solution and then in-
cubated on ice for 20 min. After the pellets were completely dis-
solved, the DNA solution was transferred to a 2.0-ml pre-spun PLG
(heavy) tube. Eight-hundred-ﬁfty microliters of cold Sevag solu-
tion was added to this tube, which was shaken by hand for 1 min,
and then centrifuged at 13,000g for 5 min. On completion, the
supernatant containing the DNA was transferred into a 2-ml tube
and 850 ml of cold isopropanol were added and incubated at
20 °C for 1 h to precipitate the DNA. The solution was cen-
trifuged at 16,000g for 10 min at 4 °C, and the supernatant was
discarded. The pellets were re-suspended in 800 ml of cold 70% v/v
ethanol and centrifuged for 3 min at 16,100g at 4 °C. The super-
natant was carefully discarded before the tubes were drained by
inversion on absorbent paper. One-hundred microliters of pre-
chilled hydrolysis buffer was added to each tube to completely re-
suspend the DNA.
3.7. Measuring the DNA concentrations
The concentrations of the DNAs isolated from the patients’ liver
tissues were measured using a spectrophotometer. Two micro-
liters of the DNA suspension was mixed with 98 ml of Milli Q water.
The absorbance of the resulting solution was measured at A260
nm and the DNA concentration was calculated.3.8. DNA hydrolysis
Based on the optimization of the hydrolysis conditions, 2 mg of
nuclease P1 and one unit of alkaline phosphatase were added to
each tube and then mixed. The solution was incubated for 1 h at
50 °C. After incubation, this solution was transferred into a 0.5 ml
pre-spun PLG (light) tube, 100 ml of Sevag solution was added and
the tube was brieﬂy mixed before being centrifuged at 13,000g for
5 min. After centrifugation, the supernatant solution containing
hydrolyzed DNA was transferred to a fresh 0.5-ml tube and stored
at 80 °C prior to the HPLC analysis.
3.9. HPLC-MS/MS analysis
The concentrations of 8-oxodG and dG were determined with
HPLC-MS/MS by an expert in Queensland Health Scientiﬁc Services
(39 Kessels Rd, Coopers Plains Qld 4108, Au). Separation was
achieved using an Altima C18 column at 35 °C and a ﬂow rate of
0.8 ml min1, with a linear gradient starting at 100% A for 0.1 min,
ramped to 80% B in 12 min, held for 2 min and then to 100% A for
1 min and equilibrated for 7 min. (A¼1% methanol/deionized
water, B¼60% methanol/deionized water, both in 5 mM Ammo-
nium Acetate). The dead space in the system modiﬁed the actual
gradient at the column and was equivalent to approximately 3 min
at 100% A before the start of the gradient. Under these conditions,
the retention times for dG and 8-oxodG were 8.58 and 8.75 min,
respectively (total run time 18 min). The column efﬂuent was split
to achieve a ﬂow rate of 0.25 ml per minute to the mass spectro-
meter. The mass spectrometer was operated in the multiple re-
action-monitoring mode using nitrogen as the collision gas and a
collision energy of 20 eV. The transitions from m/z 284.2 (Mþ Hþ)
to 168.1 for 8-oxodG and 268.2 (Mþ Hþ) to 152.1 for dG were
monitored with a residence time of 350 ms. The samples were
quantiﬁed by comparing the peak areas of the standards to the
peak areas of the samples. Using a 50-ml injection volume, the
limit of detection using this method is typically 1 mg/l for 8-oxodG
and 50 mg/l for dG. Some interference from other components
present in the sample has been noted, particularly in the dG
determination.
3.10. Statistical analysis
All statistical calculations were performed and the graphs were
plotted using GraphPad Prism software version 6.0. In the graphs
that chart the 8-oxodG ratios, all of the points cannot be shown
because some of the 8-oxodG/dG ratios deviated from the others
at the bottom of the graphs. Therefore, according to the statistical
guide of GraphPad Prism software version 6.0, the 8-oxodG/dG
ratios were ﬁrst transformed to logarithms. The logarithms of the
8-oxodG/dG ratios of the various groups of patients were eval-
uated for the normality of the distribution by the D'Agostino &
Pearson omnibus normality test to decide whether a nonpara-
metric rank-based analysis or a parametric analysis should be
used. Statistically signiﬁcant differences in the unpaired hepatic
8-oxodG/dG ratios of the two groups of patients were compared
with the Mann–Whitney U test for data without a normal dis-
tribution or with the unpaired t test for data with a normal dis-
tribution. Statistically signiﬁcant differences between the loga-
rithms of paired hepatic 8-oxodG/dG ratios of non-malignant liver
tissues and those of malignant tissues from the same HCC patients
were compared with the Wilcoxon matched-pairs signed rank test
for the data without a normal distribution or with the paired t test
for the data with a normal distribution. P values less than 0.05
were considered statistically signiﬁcant. The box-whisker plots
expressed the logarithms of the 8-oxodG/dG ratios. The results
were expressed as the means7standard derivation or as medians.
Table 3
Enzymatic hydrolysis of calf Commercial DNA under 5 different conditions.








1, nuclease P1þalkaline phos-
phatase for 1 h at 50 °C
1 44.5 35.2 79
5 44.9 40.8 90
10 41.2 33.6 81
20 39.3 33.6 85
2, heated for 5 min at 100 °C,
nuclease P1þalkaline phos-
phatase for 1 h at 50 °C
1 46.3 49.3 106
5 46.5 47.3 101
10 4.8 2.1 43
20 43.1 43.7 101
3, nuclease P1 for 1 h at 50 °C,
alkaline phosphatase for 1 h
at 37 °C
1 40.1 29.4 73
5 41.8 32.2 77
10 39.8 31.7 79
20 41.8 33.1 79
4, nuclease P1 for 10 min at
65 °C, alkaline phosphatase
for 1 h at 37 °C
1 38.2 28.3 74
5 42.5 36.6 85
10 29.5 25.9 87
20 28.1 22.4 79
5, nuclease P1 for 0.5 h at
37 °C, alkaline phosphatase
for 1 h at 37 °C
1 29.5 23.1 78
5 38.1 49 128
10 31.4 33 105
20 31.3 32.6 104
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4.1. DNA extraction
In this study, to determine the effects of temperature on the
formation of 8-oxodG during DNA extraction, human liver DNA
was extracted using the cold 4 M GTC method (4 °C) and the warm
(37 °C) RNase A/proteinase K method. These DNA samples to-
gether with commercial calf DNA used as a control (maintained at
25 °C in air) were hydrolyzed and the 8-oxodG levels were mea-
sured by HPLC-MS/MS. The results indicated that the cold 4 M GTC
method had the lowest ratios of 8-oxodG/dG, while the ratio from
the same liver tissue using the warm RNase A/proteinase K
method was increased by approximately two-fold and the 8-ox-
odG/dG ratios from the commercial calf DNA exposed to room air
were 31-fold higher (see Table 2). Additionally, the DNA yields of
the eight samples were signiﬁcantly different; the largest DNA
yield was 7.57 mg/mg, and the smallest DNA yield was 0.19 mg/mg.
The 8-oxodG levels in 2 samples could not be detected by HPLC-
MS/MS, although Table 2 showed that sufﬁcient amounts of DNA
were used.
4.2. DNA hydrolysis
One-hundred micrograms of commercial calf thymus DNA was
hydrolyzed with 1 mg, 5 mg, 10 mg or 20 mg of nuclease P1 and 1 unit
of alkaline phosphatase at 5 different temperatures and incubation
conditions. The results from these experiments are shown in Ta-
ble 3. These data revealed that the dG yields in Conditions 1, 2 and
3 were higher than those in Conditions 4 and 5. Second, the DNA
was hydrolyzed at similar levels with all concentrations of nucle-
ase P1 (1 to 20 mg) in these three conditions. Third, the 8-oxodG/
dG ratios in Conditions 1 and 3 were less than those in Conditions
2 and 5. This indicated that Conditions 1 and 3 resulted in reduced
8-oxodG production compared to Conditions 2 and 5. A previous
study supported the use of Condition 1 to hydrolyze the DNA for
8-oxodG measurements [48], and a decision was made to hydro-
lyze the DNA using Condition 1, in which the DNA was incubated
with 2 mg of nuclease P1 and 1 unit of alkaline phosphatase for 1 h
at 50 °C.
4.3. Comparisons of the logarithms of the 8-oxodG/dG ratios in the
non-malignant liver tissues to those in the malignant tissues of HCC
patients
Among the total 54 HCC cases, both non-malignant liver tissues
and malignant tissues are available for some cases, while only
non-malignant liver tissues or malignant tissues are available for
other cases. Each tissue was used to measure the 8-oxodG and dG
levels 1–6 times, and then, the 8-oxodG/dG ratios in each tissueTable 2
DNA extraction with the warm proteinase K digestion and cold 4 M GTC methods.
Method Tissues Tissue amount
(mg)
DNA a
The warm proteinase K digestion
method
Normal A 93 398
Normal B 50 269.2
Tumor 1 70 313
Tumor 2 60 280
The cold 4 M GTC method Normal A 63 477
Normal B 55 279
Tumor 1 125 n/aa
Tumor 2 60 11.9
Positive control Calf thymus DNA – 100
Calf thymus DNA – 60
a not detectedwere averaged. The 8-oxodG/dG ratios were ﬁrst transformed to
logarithms. The distribution of the logarithms of the 8-oxodG/dG
ratios in the malignant and non-malignant liver tissues was ana-
lyzed for normality with the D'Agostino and Pearson omnibus
normality test. Only the distributions of the logarithms of the
8-oxodG/dG ratios in the non-malignant tissues and malignant
tissues from Australian HCC patients were normal, while those of
the total HCC cases or the Southern African HCC patients were not
(see Fig. 1). Therefore, statistically signiﬁcant differences between
the logarithms of the 8-oxodG/dG ratios in the non-malignant liver
tissues and those in the malignant tissues of Australian HCC pa-
tients were evaluated with the unpaired t test, while those of the
total cases and the Southern African HCC patients were tested with
the Mann–Whitney U test.
The statistical analysis showed that there were signiﬁcant dif-
ferences between the logarithms of the 8-oxodG/dG ratios in the
non-malignant tissues and those in the malignant tissues of
Southern African HCC patients (p¼0.0479), while there were no
signiﬁcant differences in the total cases (p¼0.2887) or Australian
HCC patients (p¼0.7722) (see Fig. 1).
4.4. Paired comparisons of the logarithms of the 8-oxodG/dG ratios
between non-malignant liver tissues and malignant tissues of the
same HCC patients
In the previous sections, the logarithms of mixtures of the
8-oxodG/dG ratios in all non-malignant liver tissues weremount (mg) Yields of DNA (mg/
mg)
dG (mg/l) 8-oxodG (mg/l) 8-oxodG/dG
(105)
4.28 13,200 0.6 4.5
5.38 263 n/aa n/aa
4.47 9620 3 3.1
4.67 14,830 0.7 4.7
7.57 18,000 0.4 2.2
5.07 4620 n/a n/a
n/a 12,500 0.2 1.6
0.19 12,150 0.4 3.3
9800 7.6 77.5
8250 5.9 71.5
Fig. 1. Comparisons of the logarithms of the 8-oxodG/dG ratios in non-malignant liver tissues versus those in malignant tissues of HCC patients. # indicates that the
8-oxodG/dG ratios in the non-malignant liver tissues were signiﬁcantly increased compared to those in the malignant tissues of Southern African HCC patients.
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logarithms of the 8-oxodG/dG ratios in non-malignant liver tissues
were compared to those in malignant tissues from the same HCC
patients. The distributions of the logarithms of the 8-oxodG/dG
ratios in non-malignant and malignant liver tissues from the same
HCC patients were analyzed for normality with the D'Agostino &
Pearson omnibus normality test. The results showed that the
distributions of the logarithms of the 8-oxodG/dG ratios in non-
malignant liver tissues and malignant tissues of Australian HCC
patients were normal, while those in the total HCC patients or
Southern African HCC patients were not normal (see Fig. 2).
Therefore, the statistically signiﬁcant differences between the
logarithms of the 8-oxodG/dG ratios in non-malignant liver tissues
and those in malignant tissues of Australian HCC patients were
compared using the paired t test, while those in the total HCC
patients and Southern African HCC patients were compared using
the Wilcoxon matched-pairs signed rank test.
The statistical analysis showed that there was a signiﬁcant in-
crease in this ratio in the non-malignant liver tissue of Southern
African HCC patients (p¼0.0229), while there was no signiﬁcantdifference in the total cases (p¼0.3001) or Australian patients
(p¼0.1601) (see Fig. 2)
4.5. Comparison of the logarithms of the 8-oxodG/dG ratios in non-
cirrhotic and cirrhotic human liver tissue from HCC patients
When the HCC patients were separated according to the pre-
sence of cirrhosis, the normalities of the logarithms of the 8-ox-
odG/dG ratios in the non-cirrhotic liver tissues and cirrhotic liver
tissues of 31 HCC patients were evaluated with the D’Agostino and
Pearson omnibus normality test. The results showed that the
distributions of the logarithms of the 8-oxodG/dG ratios in non-
cirrhotic liver tissues the cirrhotic liver tissues of Australian HCC
patients were normal, but those of the total HCC cases or Southern
African HCC patients were not normal. Therefore, the statistically
signiﬁcant differences between the non-cirrhotic and cirrhotic li-
ver tissues of Australian HCC patients were tested with the un-
paired t test, while the differences in the total HCC patients and
Southern African HCC patients were compared with the Mann–
Whitney U test. The results demonstrated that there was no
Fig. 2. Paired comparisons of the logarithms of the 8-oxodG/dG ratios in non-malignant liver tissues to those in malignant tissues of the same HCC patients. # indicates that
the 8-oxodG/dG ratios in the non-malignant liver tissues were signiﬁcantly increased compared to those in the malignant tissues of Southern African HCC patients.
P. Li et al. / Redox Biology 8 (2016) 259–270 265signiﬁcant difference between the 8-oxodG/dG ratios in the cir-
rhotic and non-cirrhotic liver tissues from the total HCC patients
(p¼0.384), Australian HCC patients (p¼0.5042) or Southern Afri-
can HCC patients (p¼0.6539) (see Fig. 3).
4.6. Comparison of the logarithms of the 8-oxodG/dG ratios based
the on underlying cause of liver disease
The logarithms of the 8-oxodG/dG ratios in patient groups
classiﬁed according to their underlying liver disease were not
normally distributed. The logarithms of the 8-oxodG/dG ratios in
malignant and non-malignant liver tissue in various chronic liver
diseases were compared with the Mann–Whitney U test. This
analysis revealed that there were no signiﬁcant differences be-
tween the logarithms of the 8-oxodG/dG ratios in non-malignant
liver tissues and those in malignant tissues in these liver diseases
(see Fig. 4).
5. Discussion
5.1. 8-oxodG/dG exhibited an increasing trend in non-malignantliver tissues compared to malignant liver tissues
In this study, there was a trend towards increased 8-oxodG/dG
ratios in non-malignant liver tissues compared to malignant liver
tissues, although the difference was not signiﬁcant. This trend was
most obvious in Southern African patients (see Figs. 1 and 2).
Nevertheless, the data do not support the hypothesis that the
hepatic 8-oxodG/dG ratios are increased in non-malignant liver
tissues compared to HCC. The 8-oxodG/dG ratios found in this
study had skewed distributions for most of the analyzed groups,
with most groups having clustered 8-oxodG/dG values, and a small
number of outlier samples were widely separated from the group.
At least one previous study has observed that the 8-oxodG le-
vels markedly increase in non-malignant liver tissue compared to
the tumors in patients with HCC. For example, the difference be-
tween malignant liver tissue and tumors was observed in both
American and Southern African patients with HCC [44]. Another
study has shown that the 8-oxodG levels in non-malignant liver
tissues are signiﬁcantly increased compared to the corresponding
HCC tissues of the same subject and that the 8-oxodG levels are
signiﬁcantly increased in non-malignant tissues with moderate
inﬂammation compared to those with mild or no inﬂammation
Fig. 3. Comparison of the logarithms of the 8-oxodG/dG ratios in non-cirrhotic liver tissues to those in cirrhotic liver tissues of 31 HCC patients.
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non-malignant liver tissue and serum alanine aminotransferase
activity has also been observed [46]. However, several previous
studies have revealed that the 8-oxodG levels are decreased in
non-malignant livers compared to the malignant liver tissues from
the same patient. For example, 8-oxodG concentrations have been
reported to be decreased in the cancer-free surrounding tissues
compared to the malignant lung tissues [47].
A number of studies have shown that 8-oxodG is the main ROS-
and RNS-oxidized form of DNA base; moreover, 8-oxodG is a pre-
mutagenic agent, and chronic liver inﬂammation leads to the
production of ROS and RNS [48,49]. This means that the presence
of increased 8-oxodG levels in liver tissues adjacent to HCC im-
plicates 8-oxodG as a link between chronic hepatic inﬂammation
and hepatic carcinogenesis; the oxidative DNA damage in chronic
hepatic inﬂammation may lead to the malignant transformation of
hepatocytes. However, this study identiﬁed an increasing trend in
the 8-oxodG/dG ratio in non-malignant liver tissues compared to
malignant tissues of HCC patients (Figs. 1 and 2), particularly in
HCC patients with HBV (Fig. 4), but these trends were not very
signiﬁcant. This study also revealed that there was no signiﬁcantdifference in the 8-oxodG/dG ratios between the cirrhotic and
non-cirrhotic liver tissue of patients with HCC (Fig. 3) or among
HCC patients with various risk factors, including HBV, HCV, alco-
hol, Allagile's syndrome, and haemochromatosis (both before and
after de-ironing) (Fig. 4). Moreover, most comparisons of the
8-oxodG/dG ratios showed that there were no signiﬁcant differ-
ences between the patient groups and tissue types.
Previous reports show that the 8-oxodG/dG ratios in non-ma-
lignant liver tissues and malignant HCC tumors were affected by
the formation, oxidation and deletion of 8-oxodG in inﬂammatory
tissues. In liver inﬂammation, the activated immune system gen-
erates excessive ROS and RNS, which can not only form 8-oxodG
but can also decompose 8-oxodG. Recent studies have shown that
8-oxodG easily reacts with ONOO [50], 1O2 [51,52] and Fe2þ [53]
to form secondary oxidative products, as it possesses a lower re-
dox potential than guanosine [54]. For example, 8-oxodG is oxi-
dized by ONOO , at least 1000 times faster than G [55]. DNA re-
pair enzymes can also remove 8-oxodG [56].
Recent reports also revealed that 8-oxodG is not a single pro-
mutagenic agent in hepatocarcinogenesis. To date, more than 100
DNA lesions in addition to 8-oxodG have been identiﬁed [57,58],
Fig. 4. Comparison of the logarithms of the 8-oxodG/dG ratios in non-malignant liver tissues to those in malignant tissues separated by the underlying cause of liver disease.
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dative products of 8-oxodG are also pro-mutagenic agents [55].
Some oxidative products of bases have higher mutation fre-
quencies. For example, the frequencies of the G to T conversion for
oxazolone and spiroiminodihydantoin are far higher than those of
8-oxodG [59,60].
Based on above observations, the 8-oxodG/dG ratio did not
reﬂect a correlation between oxidative DNA damage in chronic
liver inﬂammation and hepatocarcinogenesis.
5.2. Many factors affected the examinations of the statistically sig-
niﬁcant differences
In this study, there was no statistically signiﬁcant difference in
the 8-oxodG/ dG ratios between non-malignant and malignant
liver tissue from Australian patients or between cirrhotic and non-
cirrhotic liver tissues of patients with HCC (see Fig. 3). The 8-ox-
odG/dG ratios in non-malignant liver tissues of HCC patients with
HBV were signiﬁcantly increased compared to the tumors in thesepatients, but signiﬁcant differences were not found in HCC pa-
tients with other chronic diseases, including alcohol, Allagile's
syndrome, and haemochromatosis (both before and after de-ir-
oning) (see Fig. 4). Most comparisons of the 8-oxodG/dG ratios
showed that there were no signiﬁcant differences between the
patient groups and tissue types. There are may be several reasons
for these observations. One possible reason was that we used an
insufﬁcient number of tissues and cases, which may have affected
these comparisons. The tissues from the Australian patients were
extremely valuable and in limited supply. Additionally, there were
only 4 cases of HCC patients with HCV, 4 cases of HCC patients
with alcohol, and 1 case of an HCC patient with Allagile's syn-
drome. This, together with the limited availability of sample ma-
terial in some groups, made comparisons of the 8-oxodG/dG ratios
difﬁcult. The second reason is that there is no correlation between
the malignant grades and these risk factors. For example, one
study found that there was no positive correlation between the
hepatic iron content and 8-oxodG concentration [45]. The hepatic
Fe and hepatic 8-oxodG levels are not correlated [44]. However,
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odG. The third reason is that there were variations in the degree of
inﬂammation/liver injury; moreover, the presence of parenchymal
elements, such as connective tissue and blood vessels, in different
tissue samples may have impacted the ﬁnal DNA yield and the
8-oxodG/dG ratio.
Previous studies have indicated that the production of arte-
factual 8-oxodG caused by high temperature, incomplete hydro-
lysis of DNA and imprecise 8-oxodG measurements lead to a lack
of signiﬁcant differences in the 8-oxodG/dG ratios between non-
malignant liver tissues and tumoural tissues. This study attempted
to remove these confounds by optimizing the conditions for DNA
isolation, DNA hydrolysis and the 8-oxodG measurements.
5.3. Inadequate DNA extraction led to an inaccurate DNA yield
During the optimization of the DNA extraction procedure, there
were problems in the earliest experiments, with large variations in
the DNA yield between samples, and there was a failure to identify
8-oxodG by HPLC. This was because the tissues were not com-
pletely homogenized or the DNA was lost during the procedures.
Thereafter, special care was taken so that the tissues were
homogenized gently to avoid rupturing the nuclear membrane,
which resulted in the loss of the DNA during the nuclei pre-
cipitation step. The homogenization tube was washed with a small
amount of homogenization buffer two or three times and the re-
sidual homogenized solution was collected into the sample. If large
amounts of lipid were present during centrifugation, the cen-
trifugation force was increased to pellet the nuclei. The crude
nuclei pellets were dissolved in cold 4 M GTC, which suppressed
any of the DNase enzymes present in the solution that otherwise
would have hydrolyzed the DNA [61].
The nuclei pellets were puriﬁed with Sevag solution. Sevag
solution consisted of 1 volume of isoamyl alcohol and 24 volumes
of chloroform. The isoamyl alcohol reduced foaming, aided the
separation, and maintained the stability of the layers of the cen-
trifuged, deproteinized solution. Chloroform causes surface dena-
turation of proteins. It is worth noting that chloroform could react
with the microcentrifuge tubes, resulting in sample leakage during
centrifugation. To avoid this problem, the DNA solution was im-
mediately transferred to a fresh tube after centrifugation.
During DNA extraction, PLG tubes were used to separate the
organic phase containing proteins and the aqueous phases con-
taining DNA. One difference in the PLG tubes compared to normal
centrifuge tubes is that these tubes contain a phase block gel that
can separate aqueous and organic media based on their density
differences. After centrifugation, the denatured protein and or-
ganic solutions are effectively trapped in the lower organic phases
of the PLG by the gel, while the DNA remains in upper aqueous
phases and can be easily removed with a pipette. The use of the
PLG tubes resulted in a DNA-containing phase that could be easily
pipetted, resulting in the recovery of 20 to 30% more nucleic acid
than with traditional methods. After cold isopropanol was added
to the solution, DNA rapidly precipitated out of solution as a
stringy gelatinous clump, unless it was sheared. If the DNA was
sheared, it was precipitated by placing the tube in a 20 °C
freezer from 20 min to overnight.
Table 2 showed that the DNA yields exhibited large variations
among samples, in which the highest DNA yield was 7.57 mg/mg,
whereas the smallest DNA yield was 0.19 mg/mg. Obviously, these
data did not represent the actual DNA concentrations. This was
because the DNA precipitate was incompletely dissolved. Large
DNA aggregates remaining in the tube produced abnormally high
or low UV absorbance readings, leading to an erroneous DNA
concentration. To avoid this problem, the DNA precipitate was
carefully dissolved by pipetting it repeatedly to obtain ahomogeneous preparation.
Additionally, the 8-oxodG levels in 2 samples could not be
detected by HPLC-MS/MS (see Table 2). One reason could be that
insufﬁcient DNA concentrations were used, although the data
showed that their DNA concentrations were very high. As men-
tioned in a previous report, if 1 mg of human liver tissues yields
approximately 1 mg of DNA [32], 50 mg of tissue would yield
10 fmol of 8-oxodG, which is close to the detection limit of 7.5 fmol
for HPLC-MS/MS. Therefore, if the tissues were not completely
homogenized or DNAwas lost during an extraction, 8-oxodG could
not be detected by HPLC-MS/MS. Therefore, great care was taken
to ensure that as much tissue was available as possible.
5.4. High temperature increased artefactual 8-oxodG production
during DNA extraction
In this study, to determine the effects of temperature on the
formation of 8-oxodG during DNA extraction and hydrolysis, hu-
man liver DNA was extracted with the cold M GTC method (4 °C)
and a warm (37 °C) RNase A/proteinase K method. These DNA
samples, together with commercial calf DNA (maintained at 25 °C
and exposed oxygen in air for a long time) as a control, were hy-
drolyzed and the 8-oxodG levels were measured by HPLC-MS/MS.
The results indicated that the cold 4 M GTC method produced the
lowest 8-oxodG yield, while the levels from the same liver tissue
using the warm RNase A/proteinase K method were increased
approximately two-fold, and the 8-oxodG/dG ratios from the
commercial calf DNA exposed to room air were increased 35-fold
(see Table 2). These results indicated that the low temperature
DNA extraction method reduced the formation of 8-oxodG during
the procedure. In addition, the much higher 8-oxodG/dG values in
commercial calf DNA compared to those of the DNA that had been
freshly extracted using both the cold M GTC method and the warm
RNase A/proteinase K may have resulted from the exposure of the
DNA to the oxygen in air during the longer incubation at room
temperature, stressing the need for refrigeration of the extracted
DNA and minimizing its exposure to air prior to analysis. There-
fore, the cold 4 M GTC method was used to extract the DNA from
the human liver tissues in this study. Additionally, samples were
stored in a 80 °C freezer, and the tissues were dissected and
homogenized and DNA was extracted in a cold room. All other
procedures were performed in a cold room as much as possible.
5.5. High temperature increased artefactual 8-oxodG production,
whereas low temperature and a short incubation time incompletely
hydrolyzed the DNA
The dG yields from 100 mg of commercial calf thymus DNA that
was hydrolyzed with 1 mg, 5 mg, 10 mg or 20 mg of nuclease P1 and
1 unit of alkaline phosphatase under Conditions 1, 2 and 3 were
more similar and larger than those under Conditions 4 and 5 (see
Table 3). This indicated that the dG concentrations were not cor-
related to those of nuclease P1 under Conditions 1, 2 and 3. This
observation was consistent with a previous study in which 10 to
25 mg of nuclease P1 did not increase DNA hydrolysis [32]. Fur-
thermore, 1 mg of nuclease P1 completely hydrolyzed 100 mg of
commercial calf thymus DNA under Conditions 1, 2 and 3.
Conditions 4 and 5 produced less dG and 8-oxodG compared to
Conditions 1, 2 and 3, but the 8-oxodG/dG ratios were still high.
This indicated that incomplete DNA hydrolysis led to an over-
estimation of the 8-oxodG levels. Condition 4 produced in-
complete hydrolysis due to the short hydrolysis time, in which
nuclease P1 hydrolyzed DNA for only 10 min, whereas the time
increased to 1 h under Conditions 1, 2 and 3 and 0.5 h under
Condition 5. The incomplete DNA hydrolysis under Condition
5 was due to the low temperature. A previous study has also
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2 produced more 8-oxodG than Conditions 1, 3, 4 and 5. This in-
dicated that high temperature produced 8-oxodG.
In summary, 1 mg of nuclease P1 completely hydrolyzed 100 mg
of DNA in 1 h at 50 °C. However, this hydrolysis was not complete
with a short incubation time (r10 min) even at 65 °C. An addi-
tional concern with heating the samples to 100 °C during hydro-
lysis was that this appeared to lead to the formation of artefactual
8-oxodG. Conditions 1 and 3 produced similar amounts of dG and
8-oxodG, but there was an additional hour-long incubation at
37 °C for hydrolysis by alkaline phosphatase. The longer hydrolysis
time and room temperature increased the risk of forming arte-
factual 8-oxodG. For these reasons, the DNA of the HCC patients in
this study was hydrolyzed with 1 unit of alkaline phosphatase and
1 mg of nuclease P1 for one hour at 50 °C.
5.6. Limitations of this study
The experiments were limited to approximately 50 mg of liver
tissue per sample. This was necessary because of the scarcity of
these tissues. This amount of tissue gave a yield of approximate 10
fmol of 8-oxodG, which was close to the detection limit of 7.5 fmol
for HPLC-MS/MS. If tissues were not completely homogenized,
DNA was lost during an extraction step, or DNA was incompletely
hydrolyzed, 8-oxodG could not be detected by HPLC-MS/MS.
Therefore, great care was taken to ensure that as much tissue was
available as possible. Second, the temperature at which the sam-
ples were processed required careful control because high tem-
peratures produced artefactual 8-oxodG values. In this experi-
ment, the samples were stored in a 80 °C freezer, and the tissues
were dissected and homogenized and DNA was extracted in a cold
room. All other procedures were performed in a cold room, as
much as possible; however, the DNA was hydrolyzed at 50 °C and
the 8-oxodG levels were measured by HPLC-MS/MS at room
temperature. These temperatures could potentially produce arte-
factual 8-oxodG. It is not known howmuch 8-oxodG was produced
during the experimental procedures and whether this inﬂuenced
our results. Third, it is not possible to determine whether the DNA
was completely hydrolyzed with nuclease P1 and alkaline phos-
phatase, even if all of the procedures are implemented to allow
complete DNA hydrolysis. If the DNA is not completely hydrolyzed,
the ratios of 8-oxodG/dG will be altered.
These temperatures could potentially produce artefactual
8-oxodG. It is not known howmuch 8-oxodG was produced during
the experimental procedures and whether this inﬂuenced our
results. Third, it is not possible to determine whether the DNA was
completely hydrolyzed with nuclease P1 and alkaline phosphatase,
even if all of the procedures are implemented to allow complete
DNA hydrolysis. If the DNA is not completely hydrolyzed, the ratios
of 8-oxodG/dG will be altered. Therefore, compared to previous
studies, this experiment was performed very carefully to reﬂect
the actual 8-oxodG values.6. Summary
This study revealed that the 8-oxodG/dG ratios tended to be
higher in most non-malignant liver tissues than those in HCC
tissues, although this was not statistically signiﬁcant. It also ap-
peared that the ratio was higher in the non-malignant liver tissue
from Southern African patients, but there was no difference in the
8-oxodG/dG ratios between non-malignant liver tissues and tu-
mors of Australian HCC patients. Additionally, this study also re-
vealed an increasing trend for 8-oxodG/dG ratios in non-malignant
liver tissues compared to tumoural tissues of patients with HBV.
These ﬁndings conﬁrmed that there was an association betweenoxidative DNA damage and chronic liver inﬂammation, but there
was no dose-dependent relationship between the 8-oxodG levels
and hepatocarcinogenesis. Due to the limitations of this study,
signiﬁcant differences in the 8-oxodG/dG ratios between the non-
cirrhotic and cirrhotic non-malignant liver tissues were not
observed.
The methods used in these experiments were suitable for
measuring the 8-oxodG levels from human liver tissues. The cold
4 M GTC method produced a sufﬁcient amount of DNA from 50 mg
of the tissues used for the analysis. Fifty micrograms of DNA were
sufﬁciently hydrolyzed using 1 mg of nuclease P1 and 1 unit of
alkaline phosphatase. The levels of artefactual 8-oxodG produced
using the optimized methods in this study were demonstrated to
be lower than those produced using the methods described in
previous studies. Despite these limitations, this study more thor-
oughly controlled for artefactual 8-oxodG/dG production and more
accurately reﬂects the actual 8-oxodG/dG levels in the samples
than previous studies.Acknowledgments
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